Skip to main content
Premium Trial:

Request an Annual Quote

Response Biomedical Signs Agreement for Sale of $7.7M of Shares to OrbiMed

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vancouver, BC-based molecular diagnostics firm Response Biomedical today announced the signing of a subscription agreement for the sale of C$8 million ($7.7 million) of its common shares to investment company OrbiMed Advisor's affiliated Asia fund.

Pursuant to the agreement, Response Biomedical will issue an aggregate of 13.3 million common shares at C$0.60 per share. Net proceeds from the placement will be used for general operating expenses, Response Biomedical said in a statement.

The company has also agreed to nominate two representatives from OrbiMed to serve on its board, provided that OrbiMed and its affiliates continue to hold at least 5.8 million shares of Response Biomedical's stock.

A shareholders' meeting is scheduled for July 27 to vote on the deal.

Wayne Kay, CEO of Response Biomedical, said that the participation of OrbiMed's affiliated Asia fund "is indicative of our expanding growth in the China market."

Under an agreement announced earlier this year, Guangzhou Wondfor Biotech will be selling Response Biomedical diagnostic products in China, building on an earlier deal with O&D Biotech for distribution of its products in the region.

"With our growing revenues, this funding will allow us to concentrate on accomplishing our operational goals as we move toward becoming cash flow positive," Kay added.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.